PubRank

Javier González-Maeso

Author PubWeight™ 26.09‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugs. Cell 2011 2.55
2 Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice. Science 2006 2.49
3 HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity. Nat Neurosci 2012 1.52
4 Maternal influenza viral infection causes schizophrenia-like alterations of 5-HT₂A and mGlu₂ receptors in the adult offspring. J Neurosci 2011 1.36
5 Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists. Neurosci Lett 2011 1.21
6 Group II metabotropic glutamate receptors and schizophrenia. Cell Mol Life Sci 2009 1.04
7 Animal models of serotonergic psychedelics. ACS Chem Neurosci 2012 1.03
8 Identification of three residues essential for 5-hydroxytryptamine 2A-metabotropic glutamate 2 (5-HT2A·mGlu2) receptor heteromerization and its psychoactive behavioral function. J Biol Chem 2012 1.00
9 Functional crosstalk and heteromerization of serotonin 5-HT2A and dopamine D2 receptors. Neuropharmacology 2011 0.99
10 p53 mediates nontranscriptional cell death in dopaminergic cells in response to proteasome inhibition. J Biol Chem 2006 0.99
11 Prenatal stress induces schizophrenia-like alterations of serotonin 2A and metabotropic glutamate 2 receptors in the adult offspring: role of maternal immune system. J Neurosci 2013 0.92
12 Validated genomic approach to study differentially expressed genes in complex tissues. Neurochem Res 2002 0.91
13 Reduced levels of serotonin 2A receptors underlie resistance of Egr3-deficient mice to locomotor suppression by clozapine. Neuropsychopharmacology 2012 0.90
14 The HIV antiretroviral drug efavirenz has LSD-like properties. Neuropsychopharmacology 2013 0.88
15 Dysregulated 5-HT(2A) receptor binding in postmortem frontal cortex of schizophrenic subjects. Eur Neuropsychopharmacol 2012 0.86
16 Distribution of prolyl endopeptidase activities in rat and human brain. Neurochem Int 2002 0.84
17 Heteromerization of G protein-coupled receptors: relevance to neurological disorders and neurotherapeutics. CNS Neurol Disord Drug Targets 2010 0.84
18 α₂-Adrenoceptor functionality in postmortem frontal cortex of depressed suicide victims. Biol Psychiatry 2010 0.82
19 Persistent effects of chronic clozapine on the cellular and behavioral responses to LSD in mice. Psychopharmacology (Berl) 2012 0.81
20 Repressive epigenetic changes at the mGlu2 promoter in frontal cortex of 5-HT2A knockout mice. Mol Pharmacol 2013 0.80
21 G protein-coupled receptor heterocomplexes in neuropsychiatric disorders. Prog Mol Biol Transl Sci 2013 0.80
22 Chronic treatment with LY341495 decreases 5-HT(2A) receptor binding and hallucinogenic effects of LSD in mice. Neurosci Lett 2013 0.79
23 Preclinical models of antipsychotic drug action. Int J Neuropsychopharmacol 2013 0.79
24 Receptor pair for schizophrenia. Pediatr Res 2008 0.78
25 HDAC2 as a new target to improve schizophrenia treatment. Expert Rev Neurother 2013 0.76